• Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
    • Mergers & Acquisitions
  • Value-based Care
    • ACO

Sheba Medical Center to Create The World’s First Fully VR-Based Hospital

by Fred Pennic 11/12/2019 Leave a Comment

Share with your friends










Submit

Sheba Medical Center to Create The First Fully VR-Based Hospital In The World Sheba Medical Center Declares Israel’s “City of Health”, Inks $350M Deal

– Sheba Medical Center is creating the world-first first VR-based hospital by leverage XRHealth’s virtual reality platform as part of their strategic innovation commitment to digital health. 

– Sheba will leverage XRHealth’s VR platform for cognitive therapy, physical therapy, pain relief, and many other applications throughout the entire hospital.

Sheba Medical Center, the leading medical center in the Middle East and an internationally recognized healthcare facility in Israel, today announced a partnership with XRHealth, a provider of extended reality and therapeutic applications to create the world’s first fully virtual reality hospital. The announcement is part of an initiative to strategically transforming the hospital into a center of innovation that embodies a startup culture and that encourages the hospital’s complete transformation to digital health.

Sheba’s Innovation Effort & Commitment to Digital Health

XRHealth, Allscripts Partner to Integrate VR/AR Platforms, Leveraging Open APIs

The hospital is guided by a strategy named Innovation ARC that stands for accelerate, redesign, and collaborate with a focus on investing in digital health, collaborating with key partners and inspiring innovation. As part of this vision, Sheba is partnering with XRHealth to use their VR platform for cognitive therapy, physical therapy, pain relief, and many other applications throughout the entire hospital.

XRHealth’s flagship product, the VRHealth Platform, is offered to healthcare facilities and provides them with VR medical apps, including cognitive assessment and training apps, motor function apps, pain management apps, and behavioral apps. The VRHealth Platform is particularly useful for medical professionals since they can analyze their patients’ data in real-time to track their recovery both on-site and remotely.

The Power of Leveraging VR in Healthcare

A recent study published in Oxford Academic demonstrates that an entorhinal cortex-based virtual reality navigation task can differentiate patients with mild cognitive impairment at low and high risk of developing dementia, with classification accuracy superior to reference cognitive tests considered to be highly sensitive to early Alzheimer’s disease. The results validate that Immersive VR has several theoretical and operational advantages over ‘desktop’ VR tasks, which are typically performed seated and thus without locomotor or proprioceptive feedback, both of which are pivotal for grid cell function (Winter et al., 2015).

Impact of Partnership with XRHealth

“With XRHealth, Sheba Medical Center believes we will be able to provide improved training for our facility, along with better and more personalized care for our patients,” said Professor Amitai Ziv, Director of Sheba’s Rehabilitation Hospital. Dr. Eyal Zimlichman, Sheba’s Chief Medical and Chief Innovation Officer added, “We’ve identified medical virtualization as one of the technologies that will transform healthcare. Within this realm, we aim to be a leader in developing new health services based on VR.”

RELATED:   HealthVoyager Selected as Winner of Lilly’s Digital Health Innovation Challenge

Tagged With: Alzheimer’s disease, dementia, digital health, healthcare innovation, Pain Management, Partners, physical therapy, risk, Sheba Medical Center, Virtual Reality, VRHealth, XRHealth

Share with your friends










Submit

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

« Massachusetts Expands Digital Health R&D Sandbox Program
EMR Replacement: Abstraction or Data Migration? »

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Recent Articles

  • 3 Themes Driving Today’s State of Gender Equity at Healthcare Startups & VCs

    3 Themes Driving Today’s State of Gender Equity at Healthcare Startups & VCs

    -... more
  • KLAS: ERP Implementation - Which Consulting Partner is the Right Fit?

    KLAS: ERP Implementation – Which Consulting Partner is the Right Fit?

    -... more
  • Analysis: November 2019 Health IT M&A Activity, Public Company Performance

    Analysis: November 2019 Health IT M&A Activity, Public Company Performance

    ... more

Most Read

  • XRHealth, Allscripts Partner to Integrate VR/AR Platforms, Leveraging Open APIs XRHealth Launches Telehealth VR/AR Platform to Connect Doctors and Patients Remotely
  • Healthcare Breach Report 2016 6 Ways Health Informatics Is Transforming Health Care
  • The State of Value-based Care in 2018: 10 Key Trends to Know The State of Value-based Care in 2018: 10 Key Trends to Know
  • 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know
  • FDA Clears Smart Diagnostic’s Finger-Prick Blood Test for U.S. Market Unlike Theranos: FDA Clears Sight Diagnostics' Finger-Prick Blood Test for U.S. Market
  • - GenapSys launches their first-of-its-kind electronic gene sequencer as well as the completion of a $90M series C funding round led by top biotech investor Foresite Capital. - GenapSys is the first & only to use direct electronic sequencing -- this allows for a simpler workflow, dramatically reduced costs, turnaround time and device size. - The GenapSys Sequencer is exceptionally accurate and 100x smaller and more affordable than current high-throughput sequencers and will significantly expand access to genetic health insights. GenapSys Inc. announced today that it has completed a $90 million funding round, led by Foresite Capital to commercialize the smallest and most affordable highly accurate sequencer ever developed. Now available for purchase, the device uses first-of-its-kind technology to deliver results at a fraction of the cost of legacy technologies, while still delivering highly accurate results. This latest investment round brings the company’s total funding to $166M to date. The new capital will be used to drive the commercial launch of the company’s first-generation product, grow GenapSys’ interdisciplinary team, and empower continued innovation. Accessible Sequencing Holds the Key to Innovation In 2019, 10 million people will die of cancer. And, yet, only 3 percent of cancer drugs tested in clinical trials since 2000 have been approved for patient use and not a single one offers a cure. Gene sequencing maybe the answer. By analyzing every component of our DNA, gene sequencing allows doctors and scientists to more effectively diagnose disease and develop better treatments. Beyond cancer, sequencing has the potential to supercharge everything from reproductive health to pathogen testing. But a single sequencing device typically costs up to $1M, limiting its reach and acting as a major bottleneck to advancement in healthcare. A Breakthrough in Sequencing with High Accuracy and Low Cost GenapSys is the first & only to use direct electronic sequencing -- this allows for a simpler workflow, dramatically reduced costs, turnaround time and device size miniaturized to the size of an iPad. It's up to 100x smaller and less expensive at under $10,000 than legacy sequencing technologies, while redefining the gold standard with over 99.9% accuracy. In other words, similar to the iPhone, sequencing will be taken to the size of a mobile device and made affordable to nearly any institution. For the $46B genomics market previously dominated by much more expensive device companies like Illumina, this could transform healthcare as we know it. Unlike many others on the market, GenapSys achieves gold standard accuracy while maintaining low costs and portability. An independent study conducted by The Jackson Laboratory, a leading global nonprofit biomedical research institution, found that GenapSys sequencers deliver consistent and excellent performance across a variety of biological samples. Recently at American Society of Human Genetics in Houston, The Jackson Laboratory presented the results of their study which found that the GenapSys sequencers are superior to optical detection methods in detecting single nucleotide mutations, a critical task used for cancer and inherited disease detection. Availability The GenapSys sequencer has been tested extensively across leading genomics labs across the nation. All studies thus far have indicated exceptional performance; published work is publicly available on BioRxiv. The GenapSys Sequencer is currently available for order in the U.S. with global sales beginning in early 2020. “We are entering a multi-decade era of genomics that will revolutionize many industries, including healthcare diagnostics, pharmaceutical discovery, personalized medicine, food testing, forensics, agriculture, biology and beyond - but until now, we’ve lacked the access necessary to realize this potential,” explained Dr. Hesaam Esfandyarpour, CEO and founder of GenapSys. “With our new sequencer, we can rapidly enable and scale genomics power to every researcher, physician, provider, and patient around the world.” GenapSys Nabs $90M to Commercialize Its Breakthrough Electronic Gene Sequencer
  • KLAS: ERP Implementation - Which Consulting Partner is the Right Fit? KLAS: ERP Implementation - Which Consulting Partner is the Right Fit?
  • Digital Health - Is It Worth It? How to Calculate ROI in Digital Health Digital Transformation In Healthcare Is Not Happening As Fast As It Should — And There’s One Reason No One is Talking About
  • Applying Automation to Healthcare_Is the Phrase Patient Engagement Overused 6 Big Benefits of Applying Automation to Healthcare
  • Job Titles for Healthcare Executives The Top 9 Most In-Demand Medical Jobs

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2019. HIT Consultant Media. All Rights Reserved. Privacy Policy |